Skip To The Main Content

Prospects for Post-Approval Change Management

syringe and vials

As new types of biologic products enter the market, the need for innovative processes continues to grow. This requires improvements in post-approval change management. ICH Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management offers a solution to post-approval change challenges in the form of a post-approval change management protocol (PACMP) (1).

You need to Login to view the full article. Please Login. Not a Member? Join today!